In the present study, we could demonstrate that the heterogeneity within ATRT–SHH is related to three newly defined robust molecular subgroups, which show similarities but also profound differences not only in tumor location, but also with respect to epigenetic landscapes, chromosomal alterations, expression signatures and outcome. This evidence concerns the gene SHH and neoplasm.